4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001415889-25-003613
Options or other derivatives
- CBO, COO and CCO acquired 450,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Hannah Brendan CBO, COO and CCO | 2025-01-28 | Grant or award · Employee Stock Option (right to buy) | +450,000 | 450,000 | D | ||
Loading xslF345X05/form4-02112025_100238.xml…